XTalks

JANUARY 28, 2022

Kimmtrak has a price tag of $18,760 per vial, which amounts to a weekly dose. Related: Cancer Blood Test Developed by University of Oxford Researchers Can Detect Metastasis. The company is expecting approval from the European Medicines Agency (EMA) soon as it prepares for a European launch in the second quarter of this year.

FDA Approval 98

FDA Approval Development Licensing Licensing 98

Rethinking Clinical Trials

AUGUST 28, 2023

 Speakers Prof Sir Martin Landray, FMedSci Professor of Medicine & Epidemiology University of Oxford Chief Executive, Protas Khair ElZarrad, PhD, MPH Director, Office of Medical Policy Center for Drug Evaluation and Research (CDER) U.S. One important note is that we specifically moved away from a checklist approach.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Development 130

Rethinking Clinical Trials

AUGUST 28, 2023

 Speakers Prof Sir Martin Landray, FMedSci Professor of Medicine & Epidemiology University of Oxford Chief Executive, Protas Khair ElZarrad, PhD, MPH Director, Office of Medical Policy Center for Drug Evaluation and Research (CDER) U.S. One important note is that we specifically moved away from a checklist approach.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Development 130

Drug Discovery World

NOVEMBER 9, 2023

Thereafter, there will be two presentations, which are: Jan Terje Andersen, PhD, Professor, Department of Pharmacology, University of Oslo; Research Group Leader, Department of Immunology, Oslo University Hospital, on: ‘Biology-based engineering of versatile antibody and albumin technologies’.

Engineer 52

Engineer Antibody Protein In-Vivo 52

pharmaphorum

NOVEMBER 19, 2021

Barely a week later, Moderna’s mRNA rival jab entered the fray, followed quickly by the AstraZeneca/Oxford University viral vector vaccine, and then this year, Janssen’s single-shot vaccine got its finger in the pie. Indeed, the price tags for Pfizer’s and Moderna’s jabs are substantial. per dose in the US and €19.50

Sales 137

Sales Vaccination Vaccine Marketing 137

The Pharma Data

MARCH 20, 2021

Medicine in Oxford, Biogazelle, a biotechnology company in Ghent, and the Centre For Proteome Research at the University of Liverpool. Highlight #1 Dr. Neil Ashley, the Single-Cell Core Facility Manager at the Weatherall Institute of Molecular Medicine (WIMM) in Oxford, U.K., Manager, Weatherall Institute, Oxford UK.

Reagent 52

Reagent RNA Bioinformatics Medicine 52

pharmaphorum

DECEMBER 7, 2021

That finding could provide some comfort to Biogen and Eisai, whose recently-approved amyloid-targeting drug Aduhelm (aducanumab) is struggling to gain traction in the market on the back of unconvincing efficacy data, safety concerns and a high price tag.

Drugs 52

Drugs Clinical Trials Clinical Trials Scientist 52